
|Articles|November 14, 2008
Valeant Pharmaceuticals acquires DermaTech
Aliso Viejo, Calif. - Valeant Pharmaceuticals has announced it has acquired DermaTech, an Australian pharmaceutical company focused on dermatology products, marketwatch reports.
Advertisement
Aliso Viejo, Calif.
- Valeant Pharmaceuticals has announced it has acquired DermaTech, an Australian pharmaceutical company focused on dermatology products, for AU$19 million, marketwatch reports.
The transaction will expand Valeant’s specialty pharmaceutical portfolio through the acquisition of key products,according to the company.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
CSU With Biochemical C1 Inhibitor Deficiency: Case Report Raises Diagnostic Questions
2
Clinicians Weigh Topical Sequencing and Escalation in Complex Atopic Dermatitis Cases
3
Common Mistakes in Managing Hair Loss and Pigmentary Disorders
4
Oral Minoxidil's Steady-State Release Avoids Cardiotoxic Peaks
5











